US 12274696
Methods of administering nalbuphine
granted A61KA61K31/485A61K9/205
Quick answer
US patent 12274696 (Methods of administering nalbuphine) held by Trevi Therapeutics, Inc. expires Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Trevi Therapeutics, Inc.
- Grant date
- Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/485, A61K9/205, A61P, A61P11/00